Ye D, Wei M, McGuire M, Huang K, Kapadia G, Herzberg O, Martin B M, Dunaway-Mariano D
Department of Chemistry, University of New Mexico, Albuquerque, New Mexico 87131, USA.
J Biol Chem. 2001 Oct 5;276(40):37630-9. doi: 10.1074/jbc.M105631200. Epub 2001 Jul 23.
Pyruvate phosphate dikinase (PPDK) catalyzes the interconversion of ATP, P(i), and pyruvate with AMP, PP(i), and phosphoenolpyruvate (PEP) in three partial reactions as follows: 1) E-His + ATP --> E-His-PP.AMP; 2) E-His-PP.AMP + P(i) --> E-His-P.AMP.PP(i); and 3) E-His-P + pyruvate --> E.PEP using His-455 as the carrier of the transferred phosphoryl groups. The crystal structure of the Clostridium symbiosum PPDK (in the unbound state) reveals a three-domain structure consisting of consecutive N-terminal, central His-455, and C-terminal domains. The N-terminal and central His-455 domains catalyze partial reactions 1 and 2, whereas the C-terminal and central His-455 domains catalyze partial reaction 3. Attempts to obtain a crystal structure of the enzyme with substrate ligands bound at the nucleotide binding domain have been unsuccessful. The object of the present study is to demonstrate Mg(II) activation of catalysis at the ATP/P(i) active site, to identify the residues at the ATP/P(i) active site that contribute to catalysis, and to identify roles for these residues based on their positions within the active site scaffold. First, Mg(II) activation studies of catalysis of E + ATP + P(i) --> E-P + AMP + PP(i) partial reaction were carried out using a truncation mutant (Tem533) in which the C-terminal domain is absent. The kinetics show that a minimum of 2 Mg(II) per active site is required for the reaction. The active site residues used for substrate/cofactor binding/activation were identified by site-directed mutagenesis. Lys-22, Arg-92, Asp-321, Glu-323, and Gln-335 mutants were found to be inactive; Arg-337, Glu-279, Asp-280, and Arg-135 mutants were partially active; and Thr-253 and Gln-240 mutants were almost fully active. The participation of the nucleotide ribose 2'-OH and alpha-P in enzyme binding is indicated by the loss of productive binding seen with substrate analogs modified at these positions. The ATP, P(i), and Mg(II) ions were docked into the PPDK N-terminal domain crevice, in an orientation consistent with substrate/cofactor binding modes observed for other members of the ATP-Grasp fold enzyme superfamily and consistent with the structure-function data. On the basis of this docking model, the ATP polyphosphate moiety is oriented/activated for pyrophosphoryl transfer through interaction with Lys-22 (gamma-P), Arg-92 (alpha-P), and the Gly-101 to Met-103 loop (gamma-P) as well as with the Mg(II) cofactors. The P(i) is oriented/activated for partial reaction 2 through interaction with Arg-337 and a Mg(II) cofactor. The Mg(II) ions are bound through interaction with Asp-321, Glu-323, and Gln-335 and substrate. Residues Glu-279, Asp-280, and Arg-135 are suggested to function in the closure of an active site loop, over the nucleotide ribose-binding site.
丙酮酸磷酸双激酶(PPDK)在三个部分反应中催化ATP、无机磷酸(P(i))和丙酮酸与AMP、焦磷酸(PP(i))和磷酸烯醇丙酮酸(PEP)的相互转化,具体如下:1)E - 组氨酸 + ATP --> E - 组氨酸 - PP.AMP;2)E - 组氨酸 - PP.AMP + P(i) --> E - 组氨酸 - P.AMP.PP(i);3)E - 组氨酸 - P + 丙酮酸 --> E.PEP,其中组氨酸455作为转移磷酰基的载体。共生梭菌PPDK的晶体结构(未结合状态)显示出由连续的N端、中央组氨酸455和C端结构域组成的三结构域结构。N端和中央组氨酸455结构域催化部分反应1和2,而C端和中央组氨酸455结构域催化部分反应3。尝试获得在核苷酸结合结构域结合有底物配体的该酶的晶体结构未成功。本研究的目的是证明Mg(II)在ATP/P(i)活性位点对催化的激活作用,确定ATP/P(i)活性位点上有助于催化的残基,并根据这些残基在活性位点支架内的位置确定其作用。首先,使用缺失C端结构域截短突变体(Tem533)对E + ATP + P(i) --> E - P + AMP + PP(i)部分反应的催化进行Mg(II)激活研究。动力学表明每个活性位点至少需要2个Mg(II)才能发生反应。通过定点诱变确定用于底物/辅因子结合/激活的活性位点残基。发现赖氨酸22、精氨酸92、天冬氨酸321、谷氨酸323和谷氨酰胺335突变体无活性;精氨酸337、谷氨酸279、天冬氨酸280和精氨酸135突变体部分有活性;苏氨酸253和谷氨酰胺240突变体几乎完全有活性。在这些位置修饰的底物类似物导致有效结合丧失,表明核苷酸核糖2'-OH和α-P参与酶结合。ATP、P(i)和Mg(II)离子以与ATP - Grasp折叠酶超家族其他成员观察到的底物/辅因子结合模式一致且与结构 - 功能数据一致的方向对接至PPDK N端结构域裂隙中。基于该对接模型,ATP多磷酸部分通过与赖氨酸22(γ-P)、精氨酸92(α-P)以及甘氨酸101至甲硫氨酸103环(γ-P)以及Mg(II)辅因子相互作用而定向/激活以进行焦磷酸转移。P(i)通过与精氨酸337和一个Mg(II)辅因子相互作用而定向/激活以进行部分反应2。Mg(II)离子通过与天冬氨酸321、谷氨酸32亚基和谷氨酰胺335以及底物相互作用而结合。推测谷氨酸279、天冬氨酸280和精氨酸135在核苷酸核糖结合位点上方的活性位点环的闭合中起作用。